Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?
about
Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinomaNon-invasive imaging of angiogenesis in head and neck squamous cell carcinomaPerfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients.CT perfusion can predict overexpression of CXCL8 (interleukin-8) in head and neck squamous cell carcinoma.Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck.Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaCombined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyPretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neckThe promise of dynamic contrast-enhanced imaging in radiation therapyEarly prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study.Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases.Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.Pretreatment Intra-Voxel Incoherent Motion Diffusion-Weighted Imaging (IVIM-DWI) in Predicting Induction Chemotherapy Response in Locally Advanced Hypopharyngeal CarcinomaDiffusion-weighted imaging in head and neck cancers.CT perfusion in oncology: how to do it.Newer imaging techniques in head and neck cancer.Multiparametric PET/CT in oncology.Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings.Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.
P2860
Q26825536-ED9E5E36-1AAD-44F9-AC13-702164129717Q34029591-9D51A6FC-864F-460C-8F4B-6B78C7CB1D0BQ34550344-564C68D0-6790-4110-8B75-B74CE5F09A97Q34729776-7BE81C3C-944F-4F3A-BBD9-2C3C4D7B2641Q35184804-BFAE4274-8DE0-4670-B84F-FADD5290AEB2Q35648944-E470F840-D60E-4A05-B061-41AEB2ADE073Q35776891-70E60A8B-4910-4B2D-86FD-F7B4CBA36A54Q36173661-35231961-24FF-4353-8F4C-DD3E606EFA2AQ36194563-BEFAB636-8862-4D8E-B510-635E479A3CF2Q36416979-5A49EBC0-F74F-41B6-BBCC-3E6A744E029FQ36547400-24A62C46-10B5-442C-960F-6E5DDFD613B4Q36747134-AF2EBE1E-510D-4C13-9D94-202EC55EE1A3Q36802886-57A690F4-0183-447A-8339-702320000E41Q37141394-6D1A2B03-7AD7-48A8-A544-FC687C980475Q37170947-5876687F-733C-417E-9705-A3FBD64CFCD3Q37207133-9DC074CE-AEAA-47C7-B0F7-A3529E7D520EQ37469917-3B67654B-17FD-4B75-97B2-E2C5F360EEA8Q37693472-850F7D60-1EA4-4157-B9F5-1CE584820120Q38038842-C42BF0E4-8FF0-4912-A8A8-1D9FC0FE9653Q38047768-3BE3CFAD-8146-45B2-8C6D-14E55D07FC16Q38367091-DC2610C3-211E-40C9-BB4A-98BB5285336BQ39886168-946726A6-79D4-4187-B517-564D88CC7534Q41894700-3869E6D5-AF17-4993-A870-26CE83F33F6EQ42365356-951DA2BF-7D4F-4C41-A710-47030DD64991Q52723563-A07E9008-8C45-4E28-90F6-AA6B077917FC
P2860
Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Can pretreatment CT perfusion ...... d with induction chemotherapy?
@en
type
label
Can pretreatment CT perfusion ...... d with induction chemotherapy?
@en
prefLabel
Can pretreatment CT perfusion ...... d with induction chemotherapy?
@en
P2093
P1476
Can pretreatment CT perfusion ...... d with induction chemotherapy?
@en
P2093
P304
P577
2007-02-01T00:00:00Z